|
US8450112B2
(en)
|
2008-04-09 |
2013-05-28 |
Maxcyte, Inc. |
Engineering and delivery of therapeutic compositions of freshly isolated cells
|
|
US8507222B2
(en)
|
2010-09-21 |
2013-08-13 |
Altor Bioscience Corporation |
Multimeric IL-15 soluble fusion molecules and methods of making and using same
|
|
US10967298B2
(en)
|
2012-03-15 |
2021-04-06 |
Flodesign Sonics, Inc. |
Driver and control for variable impedence load
|
|
US9745548B2
(en)
|
2012-03-15 |
2017-08-29 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US10689609B2
(en)
|
2012-03-15 |
2020-06-23 |
Flodesign Sonics, Inc. |
Acoustic bioreactor processes
|
|
US9752113B2
(en)
|
2012-03-15 |
2017-09-05 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US9458450B2
(en)
|
2012-03-15 |
2016-10-04 |
Flodesign Sonics, Inc. |
Acoustophoretic separation technology using multi-dimensional standing waves
|
|
US9950282B2
(en)
|
2012-03-15 |
2018-04-24 |
Flodesign Sonics, Inc. |
Electronic configuration and control for acoustic standing wave generation
|
|
US10322949B2
(en)
|
2012-03-15 |
2019-06-18 |
Flodesign Sonics, Inc. |
Transducer and reflector configurations for an acoustophoretic device
|
|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US10737953B2
(en)
|
2012-04-20 |
2020-08-11 |
Flodesign Sonics, Inc. |
Acoustophoretic method for use in bioreactors
|
|
EP4282419A1
(en)
|
2012-12-20 |
2023-11-29 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
EP2948544A4
(en)
|
2013-01-28 |
2016-08-03 |
St Jude Childrens Res Hospital |
CHIMERIC RECEPTOR WITH NKG2D SPECIFICITY FOR CELL THERAPY AGAINST CANCER AND INFECTION DISEASES
|
|
US12590955B2
(en)
|
2013-03-15 |
2026-03-31 |
Zeon Corporation |
Methods and systems for processing particles
|
|
US11493428B2
(en)
|
2013-03-15 |
2022-11-08 |
Gpb Scientific, Inc. |
On-chip microfluidic processing of particles
|
|
US20150064153A1
(en)
|
2013-03-15 |
2015-03-05 |
The Trustees Of Princeton University |
High efficiency microfluidic purification of stem cells to improve transplants
|
|
EP3608022A1
(en)
|
2013-03-15 |
2020-02-12 |
The Trustees of Princeton University |
Methods and devices for high throughput purification
|
|
EP3783098A1
(en)
*
|
2013-05-14 |
2021-02-24 |
Board Of Regents, The University Of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
CA2913052A1
(en)
|
2013-05-24 |
2014-11-27 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor-targeting monoclonal antibodies
|
|
US9745569B2
(en)
|
2013-09-13 |
2017-08-29 |
Flodesign Sonics, Inc. |
System for generating high concentration factors for low cell density suspensions
|
|
WO2015105955A1
(en)
|
2014-01-08 |
2015-07-16 |
Flodesign Sonics, Inc. |
Acoustophoresis device with dual acoustophoretic chamber
|
|
WO2015112626A1
(en)
*
|
2014-01-21 |
2015-07-30 |
June Carl H |
Enhanced antigen presenting ability of car t cells by co-introduction of costimulatory molecules
|
|
US10189908B2
(en)
|
2014-02-05 |
2019-01-29 |
The University Of Chicago |
Chimeric antigen receptors recognizing cancer-specific TN glycopeptide variants
|
|
KR102375998B1
(ko)
|
2014-02-14 |
2022-03-21 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
키메라 항원 수용체 및 제조방법
|
|
US10611837B2
(en)
|
2014-04-10 |
2020-04-07 |
Seattle Children's Hospital |
Transgene genetic tags and methods of use
|
|
CA2946312A1
(en)
|
2014-04-23 |
2015-10-29 |
Juno Therapeutics, Inc. |
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
|
|
DK3143134T3
(da)
|
2014-05-15 |
2021-01-04 |
Nat Univ Singapore |
Modificerede, naturlige dræberceller og anvendelser deraf
|
|
KR102762243B1
(ko)
*
|
2014-06-30 |
2025-02-05 |
알토 바이오사이언스 엘엘씨 |
Il-15-베이즈드 분자 및 이의 사용 방법
|
|
US9744483B2
(en)
|
2014-07-02 |
2017-08-29 |
Flodesign Sonics, Inc. |
Large scale acoustic separation device
|
|
GB201506423D0
(en)
|
2015-04-15 |
2015-05-27 |
Tc Biopharm Ltd |
Gamma delta T cells and uses thereof
|
|
BR112017001183A2
(pt)
|
2014-07-21 |
2017-11-28 |
Novartis Ag |
tratamento de câncer usando receptor de antígeno quimérico anti-bcma humanizado
|
|
TWI719942B
(zh)
|
2014-07-21 |
2021-03-01 |
瑞士商諾華公司 |
使用ｃｄ３３嵌合抗原受體治療癌症
|
|
SG10201913782UA
(en)
|
2014-07-21 |
2020-03-30 |
Novartis Ag |
Treatment of cancer using a cll-1 chimeric antigen receptor
|
|
BR112017007765B1
(pt)
|
2014-10-14 |
2023-10-03 |
Halozyme, Inc |
Composições de adenosina deaminase-2 (ada2), variantes do mesmo e métodos de usar o mesmo
|
|
CA2964783C
(en)
|
2014-11-05 |
2024-01-23 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (car) to selectively target protein complexes
|
|
JP6797803B2
(ja)
*
|
2014-12-31 |
2020-12-09 |
セルジーン コーポレイション |
ナチュラルキラー細胞を用いて血液障害、固形腫瘍、又は感染性疾患を治療する方法
|
|
US20180148480A1
(en)
*
|
2015-01-16 |
2018-05-31 |
The Johns Hopkins University |
Synthetic enhancement of the t-cell armamentarium as an anti-cancer therapy
|
|
WO2016118857A1
(en)
|
2015-01-23 |
2016-07-28 |
Musc Foundation For Research Development |
Cytokine receptor genes and the use thereof to enhance therapy
|
|
CN107683289B
(zh)
|
2015-01-26 |
2021-08-06 |
芝加哥大学 |
IL13Rα2结合剂和其在癌症治疗中的用途
|
|
WO2016123143A1
(en)
|
2015-01-26 |
2016-08-04 |
The University Of Chicago |
CAR T-CELLS RECOGNIZING CANCER-SPECIFIC IL 13Rα2
|
|
WO2016127257A1
(en)
*
|
2015-02-12 |
2016-08-18 |
University Health Network |
Chimeric antigen receptors
|
|
US10808230B2
(en)
|
2015-02-24 |
2020-10-20 |
Board Of Regents, The University Of Texas System |
Selection methods for genetically-modified T cells
|
|
KR102615825B1
(ko)
*
|
2015-03-11 |
2023-12-21 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
전위효소 폴리펩타이드 및 이의 용도
|
|
AU2016249005B2
(en)
|
2015-04-17 |
2022-06-16 |
Novartis Ag |
Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
|
US11021699B2
(en)
|
2015-04-29 |
2021-06-01 |
FioDesign Sonics, Inc. |
Separation using angled acoustic waves
|
|
GB201507368D0
(en)
*
|
2015-04-30 |
2015-06-17 |
Ucl Business Plc |
Cell
|
|
EP4286511A3
(en)
*
|
2015-06-12 |
2024-03-06 |
Lentigen Technology, Inc. |
Method to treat cancer with engineered t-cells
|
|
US11655452B2
(en)
*
|
2015-06-25 |
2023-05-23 |
Icell Gene Therapeutics Inc. |
Chimeric antigen receptors (CARs), compositions and methods of use thereof
|
|
EP3322424B1
(en)
*
|
2015-07-16 |
2023-10-11 |
Yeda Research and Development Co., Ltd. |
Use of anti third party central memory t cells
|
|
CA2992551A1
(en)
|
2015-07-21 |
2017-01-26 |
Novartis Ag |
Methods for improving the efficacy and expansion of immune cells
|
|
US11459540B2
(en)
|
2015-07-28 |
2022-10-04 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
|
US11474085B2
(en)
|
2015-07-28 |
2022-10-18 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
|
EP3328994A4
(en)
*
|
2015-07-31 |
2019-04-17 |
Memorial Sloan-Kettering Cancer Center |
CD56-Faced Antigen-Binding Proteins and Uses Thereof
|
|
US10976232B2
(en)
|
2015-08-24 |
2021-04-13 |
Gpb Scientific, Inc. |
Methods and devices for multi-step cell purification and concentration
|
|
HK1258218A1
(zh)
|
2015-09-15 |
2019-11-08 |
Board Of Regents, The University Of Texas System |
T细胞受体(tcr)结合抗体及其应用
|
|
EP3747472B1
(en)
|
2015-09-15 |
2024-04-03 |
Acerta Pharma B.V. |
Therapeutic combinations of a cd19 inhibitor and a btk inhibitor
|
|
EP3368075B1
(en)
|
2015-10-27 |
2020-01-29 |
Board of Regents, The University of Texas System |
Chimeric antigen receptor molecules and uses thereof
|
|
SG11201803419PA
(en)
|
2015-10-30 |
2018-05-30 |
The Regents Of The Universtiy Of California |
Methods of generating t-cells from stem cells and immunotherapeutic methods using the t-cells
|
|
US10691773B2
(en)
|
2015-12-30 |
2020-06-23 |
General Electric Company |
Cell processing techniques
|
|
WO2017123548A1
(en)
*
|
2016-01-14 |
2017-07-20 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Tumor-specific ifna secretion by car t-cells to reprogram the solid tumor microenvironment
|
|
US20200063157A9
(en)
*
|
2016-02-26 |
2020-02-27 |
Poseida Therapeutics, Inc. |
Transposon system and methods of use
|
|
US11111505B2
(en)
|
2016-03-19 |
2021-09-07 |
Exuma Biotech, Corp. |
Methods and compositions for transducing lymphocytes and regulating the activity thereof
|
|
US12590321B2
(en)
|
2016-03-19 |
2026-03-31 |
Exuma Biotech Corp. |
Methods and compositions for genetically modifying and expanding lymphocytes and regulating the activity thereof
|
|
CU24649B1
(es)
*
|
2016-03-19 |
2023-02-13 |
Exuma Biotech Corp |
Retrovirus recombinantes incompetentes de replicación para la transducción de linfocitos y expansión regulada de los mismos
|
|
US11325948B2
(en)
|
2016-03-19 |
2022-05-10 |
Exuma Biotech Corp. |
Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPL
|
|
CA3019650C
(en)
|
2016-04-01 |
2023-07-25 |
Kite Pharma, Inc. |
Chimeric receptors and methods of use thereof
|
|
TWI795133B
(zh)
|
2016-04-01 |
2023-03-01 |
美商凱特製藥公司 |
Ｂｃｍａ結合分子類及彼等之用途
|
|
ES2891578T3
(es)
|
2016-04-01 |
2022-01-28 |
Kite Pharma Inc |
Antígeno quimérico y receptores de células T y métodos de uso
|
|
EP3439675A4
(en)
|
2016-04-08 |
2019-12-18 |
Purdue Research Foundation |
METHOD AND COMPOSITIONS FOR CAR-T CELL THERAPY
|
|
US11446398B2
(en)
|
2016-04-11 |
2022-09-20 |
Obsidian Therapeutics, Inc. |
Regulated biocircuit systems
|
|
US10188749B2
(en)
|
2016-04-14 |
2019-01-29 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
|
EP4628587A3
(en)
|
2016-04-15 |
2026-02-25 |
Memorial Sloan Kettering Cancer Center |
Transgenic t cell and chimeric antigen receptor t cell compositions and related methods
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
US11085035B2
(en)
|
2016-05-03 |
2021-08-10 |
Flodesign Sonics, Inc. |
Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
|
|
CN105968210B
(zh)
*
|
2016-05-13 |
2019-05-31 |
深圳生创精准医疗科技有限公司 |
靶向cd22的强杀伤性嵌合抗原受体t细胞及其在制备治疗肿瘤的药物中的用途
|
|
EP4011381A1
(en)
*
|
2016-06-03 |
2022-06-15 |
Memorial Sloan-Kettering Cancer Center |
Adoptive cell therapies as early treatment options
|
|
CA3025667A1
(en)
|
2016-06-08 |
2017-12-14 |
Intrexon Corporation |
Cd33 specific chimeric antigen receptors
|
|
CN109715196A
(zh)
|
2016-06-13 |
2019-05-03 |
转矩医疗股份有限公司 |
用于促进免疫细胞功能的组合物和方法
|
|
CN109562126A
(zh)
*
|
2016-06-24 |
2019-04-02 |
美商生物细胞基因治疗有限公司 |
嵌合抗原受体(car)、组合物及其使用方法
|
|
CA3031289A1
(en)
*
|
2016-07-18 |
2018-01-25 |
Helix Biopharma Corp. |
Car immune cells to treat cancer
|
|
ES2877820T3
(es)
*
|
2016-08-01 |
2021-11-17 |
Health Research Inc |
Composiciones y métodos para la clonación rápida de receptores de células T
|
|
CN106222201B
(zh)
*
|
2016-08-27 |
2017-11-28 |
北京艺妙神州医疗科技有限公司 |
一种制备car‑t细胞的方法以及制得的car‑t细胞及其应用
|
|
CA3036926C
(en)
*
|
2016-09-30 |
2022-05-31 |
Poseida Therapeutics, Inc. |
Modified stem cell memory t cells, methods of making and methods of using same
|
|
US20190119636A1
(en)
|
2017-10-23 |
2019-04-25 |
Poseida Therapeutics, Inc. |
Modified stem cell memory t cells, methods of making and methods of using same
|
|
JP7623784B2
(ja)
|
2016-10-13 |
2025-01-29 |
ジュノー セラピューティクス インコーポレイテッド |
トリプトファン代謝経路調節剤を含む免疫療法の方法および組成物
|
|
WO2018075830A1
(en)
|
2016-10-19 |
2018-04-26 |
Flodesign Sonics, Inc. |
Affinity cell extraction by acoustics
|
|
US20190290728A1
(en)
*
|
2016-10-21 |
2019-09-26 |
Children's Medical Center Corporation |
Methods related to breaking t cell exhaustion
|
|
EP3548055A4
(en)
|
2016-12-02 |
2020-08-19 |
University of Southern California |
SYNTHETIC IMMUNE RECEPTORS AND THEIR PROCESSES FOR USE
|
|
US20200095547A1
(en)
*
|
2016-12-02 |
2020-03-26 |
Darya ALIZADEH |
Methods for manufacturing t cells expressing of chimeric antigen receptors and other receptors
|
|
JP7275043B2
(ja)
|
2016-12-16 |
2023-05-17 |
ビー－モーゲン・バイオテクノロジーズ，インコーポレーテッド |
増大したｈＡＴファミリートランスポゾン媒介遺伝子導入ならびに関連する組成物、システムおよび方法
|
|
US11278570B2
(en)
|
2016-12-16 |
2022-03-22 |
B-Mogen Biotechnologies, Inc. |
Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
|
|
GB201621889D0
(en)
*
|
2016-12-21 |
2017-02-01 |
Autolus Ltd |
Cell
|
|
EP3567049A4
(en)
|
2016-12-28 |
2020-08-26 |
Green Cross Lab Cell Corporation |
CHEMERICAL ANTIGENIC RECEPTOR AND NATURAL KILLER CELLS EXPRESSING THE SAME
|
|
CN108250301A
(zh)
*
|
2016-12-29 |
2018-07-06 |
天津天锐生物科技有限公司 |
一种多靶点嵌合抗原受体
|
|
WO2018126317A1
(en)
*
|
2017-01-05 |
2018-07-12 |
Helix Biopharma Corporation |
Vegfr-2 car immune cells to treat cancers
|
|
CN110121336A
(zh)
|
2017-01-05 |
2019-08-13 |
弗莱德哈钦森癌症研究中心 |
改善疫苗功效的系统和方法
|
|
EP3568474A1
(en)
*
|
2017-01-10 |
2019-11-20 |
Intrexon Corporation |
Modulating expression of polypeptides via new gene switch expression systems
|
|
JP7280827B2
(ja)
*
|
2017-01-18 |
2023-05-24 |
エクスマ バイオテック コーポレイション |
Ａｘｌまたはｒｏｒ２に対するキメラ抗原受容体およびその使用方法
|
|
US11649288B2
(en)
|
2017-02-07 |
2023-05-16 |
Seattle Children's Hospital |
Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents
|
|
WO2018160622A1
(en)
|
2017-02-28 |
2018-09-07 |
Endocyte, Inc. |
Compositions and methods for car t cell therapy
|
|
KR102746901B1
(ko)
*
|
2017-03-03 |
2024-12-26 |
옵시디안 테라퓨틱스, 인크. |
Cd19 조성물 및 면역요법을 위한 방법
|
|
KR102879522B1
(ko)
*
|
2017-03-03 |
2025-11-04 |
엑수마 바이오테크, 코포레이션 |
림프구를 형질도입 및 팽창시키고 이들의 활성을 조절하기 위한 방법 및 조성물
|
|
US11629340B2
(en)
|
2017-03-03 |
2023-04-18 |
Obsidian Therapeutics, Inc. |
DHFR tunable protein regulation
|
|
WO2018169922A2
(en)
|
2017-03-13 |
2018-09-20 |
Kite Pharma, Inc. |
Chimeric antigen receptors for melanoma and uses thereof
|
|
CA3056591A1
(en)
|
2017-03-27 |
2018-10-04 |
National University Of Singapore |
Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
|
|
BR112019019917A2
(pt)
|
2017-03-27 |
2020-04-22 |
Nat Univ Singapore |
receptores quiméricos nkg2d truncados e seus usos em imunoterapia de células exterminadoras naturais
|
|
US20200101108A1
(en)
|
2017-03-31 |
2020-04-02 |
The Board Of Trustees Of The Le-Land Standford Junior University |
Methods of treating t cell exhaustion by inhibiting or modulating t cell receptor signaling
|
|
MX2019012295A
(es)
*
|
2017-04-14 |
2020-02-07 |
Tollnine Inc |
Polinucleotidos inmunomoduladores, conjugados de anticuerpos de los mismos y metodos para su uso.
|
|
SG11201909331UA
(en)
*
|
2017-04-18 |
2019-11-28 |
Fujifilm Cellular Dynamics Inc |
Antigen-specific immune effector cells
|
|
EP3612210A4
(en)
*
|
2017-04-19 |
2021-01-27 |
Board Of Regents, The University Of Texas System |
MANIPULATED ANTIGEN RECEPTORS EXPRESSING IMMUNE CELLS
|
|
AU2018257894A1
(en)
|
2017-04-24 |
2019-10-31 |
Kite Pharma, Inc. |
Humanized antigen-binding domains against CD19 and methods of use
|
|
US12384830B2
(en)
|
2017-06-02 |
2025-08-12 |
Regents Of The University Of Minnesota |
Compositions and methods for improving immunotherapy
|
|
EP3638262A4
(en)
|
2017-06-16 |
2021-03-24 |
Mayo Foundation for Medical Education and Research |
MATERIALS AND METHODS FOR INCREASING IMMUNE REACTION
|
|
CA3287539A1
(en)
|
2017-06-21 |
2026-03-02 |
Icell Gene Therapeutics Llc |
CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOF
|
|
CA3068286A1
(en)
*
|
2017-06-22 |
2018-12-27 |
Board Of Regents, The University Of Texas System |
Methods for producing regulatory immune cells and uses thereof
|
|
CA3070998A1
(en)
*
|
2017-07-25 |
2019-01-31 |
Board Of Regents, The University Of Texas System |
Enhanced chimeric antigen receptors and use thereof
|
|
CN109337872B
(zh)
*
|
2017-07-27 |
2023-06-23 |
上海细胞治疗研究院 |
高效扩增car-t细胞的人工抗原递呈细胞及其用途
|
|
EP3664835B1
(en)
*
|
2017-08-09 |
2024-10-23 |
Juno Therapeutics, Inc. |
Methods and compositions for preparing genetically engineered cells
|
|
CN111065399B
(zh)
|
2017-09-01 |
2023-11-28 |
Gpb科学有限公司 |
使用微流体制备治疗活性细胞的方法
|
|
IL315340A
(en)
|
2017-09-01 |
2024-10-01 |
Lonza Walkersville Inc |
End-to-end cell therapy automation
|
|
CA3074826A1
(en)
|
2017-09-05 |
2019-03-14 |
Torque Therapeutics, Inc. |
Therapeutic protein compositions and methods of making and using the same
|
|
EP3735460A4
(en)
*
|
2017-09-18 |
2021-08-11 |
Exuma Biotech Corp. |
METHODS AND COMPOSITIONS FOR THE GENETIC MODIFICATION AND EXPANSION OF LYMPHOCYTES AND THE REGULATION OF THE ACTIVITY OF THE LATTER
|
|
CN117721084A
(zh)
|
2017-10-12 |
2024-03-19 |
美商生物细胞基因治疗有限公司 |
靶向多种抗原的复合嵌合抗原受体（cCAR）及其组成和使用方法
|
|
US11771718B2
(en)
|
2017-10-18 |
2023-10-03 |
Precigen, Inc. |
Polypeptide compositions comprising spacers
|
|
WO2019094360A1
(en)
*
|
2017-11-07 |
2019-05-16 |
The Board Of Regents Of The University Of Texas System |
Targeting lilrb4 with car-t or car-nk cells in the treatment of cancer
|
|
US11649294B2
(en)
|
2017-11-14 |
2023-05-16 |
GC Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
KR20250070609A
(ko)
*
|
2017-11-14 |
2025-05-20 |
아르셀엑스, 인크. |
다기능성 면역 세포 요법
|
|
AU2018367452B2
(en)
|
2017-11-14 |
2024-06-13 |
Memorial Sloan-Kettering Cancer Center |
IL-36 secreting immunoresponsive cells and uses thereof
|
|
KR102774451B1
(ko)
|
2017-11-14 |
2025-02-28 |
앱클론(주) |
항-her2 항체 또는 그의 항원 결합 단편, 및 이를 포함하는 키메라 항원 수용체
|
|
EP3710471A1
(en)
|
2017-11-16 |
2020-09-23 |
Kite Pharma, Inc. |
Modified chimeric antigen receptors and methods of use
|
|
CN107974460B
(zh)
*
|
2017-11-30 |
2021-06-01 |
山东兴瑞生物科技有限公司 |
针对hiv-1的嵌合抗原受体基因、具有该基因的质粒、t细胞、试剂盒及应用
|
|
KR102439221B1
(ko)
|
2017-12-14 |
2022-09-01 |
프로디자인 소닉스, 인크. |
음향 트랜스듀서 구동기 및 제어기
|
|
CN108251376B
(zh)
*
|
2017-12-21 |
2021-08-13 |
王文举 |
人工抗原递呈细胞及其构建方法与在嵌合抗原受体t细胞扩增中的应用
|
|
CU24545B1
(es)
*
|
2017-12-29 |
2021-09-07 |
Ct Ingenieria Genetica Biotecnologia |
Péptido antagonista de la actividad de la interleucina-15
|
|
EP3735265A4
(en)
|
2018-01-03 |
2021-11-10 |
Qu Biologics Inc. |
INNATE TARGETING OF ADOPTIVE CELL THERAPIES
|
|
EP3735255A4
(en)
*
|
2018-01-05 |
2021-09-22 |
Maxcyte, Inc. |
CHRONIC CANCER TREATMENT BY CARS
|
|
KR20250099256A
(ko)
|
2018-01-18 |
2025-07-01 |
프레드 허친슨 캔서 센터 |
세포 활성화 상태를 조절함으로써 생체내 면역 세포의 염증 상태의 변경
|
|
US11311576B2
(en)
|
2018-01-22 |
2022-04-26 |
Seattle Children's Hospital |
Methods of use for CAR T cells
|
|
EP3743083A4
(en)
*
|
2018-01-23 |
2021-11-03 |
Vanderbilt University |
SELF-ANTIGEN SPECIFIC T-LYMPHOCYTES AS VACCINES TO INCREASE ENGINEERING AND STABILITY OF AUTOLOGOUS TRANSFER
|
|
CN110093351B
(zh)
*
|
2018-01-29 |
2023-06-23 |
华南生物医药研究院 |
可分离的核酸、多肽、重组载体、重组细胞及应用
|
|
US12312416B2
(en)
|
2018-02-06 |
2025-05-27 |
Seattle Children's Hospital |
Fluorescein-specific cars exhibiting optimal t cell function against FL-PLE labelled tumors
|
|
BR112020016176A2
(pt)
|
2018-02-09 |
2022-02-22 |
Immatics Us Inc |
Métodos de transdução de uma célula t, célula t transduzida geneticamente, composição farmacêutica, métodos de preparação de uma população de células t e uso da célula t
|
|
EP3749685A4
(en)
|
2018-02-09 |
2021-12-22 |
National University of Singapore |
ACTIVATOR CHEMERIC RECEPTORS AND THEIR USES IN NATURAL KILLING CELL IMMUNOTHERAPY
|
|
US20200399383A1
(en)
*
|
2018-02-13 |
2020-12-24 |
Novartis Ag |
Chimeric antigen receptor therapy in combination with il-15r and il15
|
|
CA3177757A1
(en)
|
2018-02-16 |
2019-08-22 |
Kite Pharma, Inc. |
Modified pluripotent stem cells and methods of making and use
|
|
US12473336B2
(en)
|
2018-02-21 |
2025-11-18 |
Board Of Regents, The University Of Texas System |
Methods for activation and expansion of natural killer cells and uses thereof
|
|
AU2019225174B2
(en)
|
2018-02-23 |
2025-11-20 |
Endocyte, Inc. |
Sequencing method for CAR T cell therapy
|
|
EA202091984A1
(ru)
*
|
2018-03-14 |
2021-02-18 |
Сиэтл Чилдрен'С Хоспитал (Дба Сиэтл Чилдрен'С Ресёрч Инститьют) |
Направленная дзетакинами т-клеточная иммунотерапия, нацеленная на рецептор il-13 альфа 2
|
|
EP3765041A4
(en)
*
|
2018-03-14 |
2021-12-22 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
IL-13 CHIMERIC RECEPTOR ALPHA 2 (IL13RA2) ANTIGEN RECEPTOR FOR T-CELL T-CELL IMMUNOTHERAPY
|
|
JP7334985B2
(ja)
|
2018-04-02 |
2023-08-29 |
ナショナル ユニヴァーシティー オブ シンガポール |
免疫細胞で発現される膜結合抗サイトカイン非シグナル伝達バインダーによるヒトサイトカインの中和
|
|
CA3095757A1
(en)
|
2018-04-06 |
2019-10-10 |
The Regents Of The University Of California |
Methods of treating glioblastomas
|
|
CA3096202A1
(en)
|
2018-04-06 |
2019-10-10 |
The Regents Of The University Of California |
Methods of treating egfrviii expressing glioblastomas
|
|
US10869888B2
(en)
|
2018-04-17 |
2020-12-22 |
Innovative Cellular Therapeutics CO., LTD. |
Modified cell expansion and uses thereof
|
|
CN112055695A
(zh)
*
|
2018-05-01 |
2020-12-08 |
弗莱德哈钦森癌症研究中心 |
用于基因表达的纳米粒子和其用途
|
|
TWI869346B
(zh)
|
2018-05-30 |
2025-01-11 |
瑞士商諾華公司 |
Ｅｎｔｐｄ２抗體、組合療法、及使用該等抗體和組合療法之方法
|
|
US11319380B2
(en)
*
|
2018-06-04 |
2022-05-03 |
Precigen, Inc. |
MUC16 specific chimeric antigen receptors and uses thereof
|
|
WO2019241315A1
(en)
|
2018-06-12 |
2019-12-19 |
Obsidian Therapeutics, Inc. |
Pde5 derived regulatory constructs and methods of use in immunotherapy
|
|
WO2019241241A1
(en)
*
|
2018-06-12 |
2019-12-19 |
Apdn (B.V.I), Inc. |
Engineered lymphocyte compositions, methods and systems
|
|
TWI890660B
(zh)
|
2018-06-13 |
2025-07-21 |
瑞士商諾華公司 |
Bcma 嵌合抗原受體及其用途
|
|
CA3104288A1
(en)
|
2018-06-21 |
2019-12-26 |
B-Mogen Biotechnologies, Inc. |
Enhanced hat family transposon-mediated gene transfer and associated compositions, systems, and methods
|
|
AU2019301070B2
(en)
|
2018-07-09 |
2025-09-11 |
Precigen, Inc. |
Fusion constructs and methods of using thereof
|
|
CA3105816A1
(en)
|
2018-07-10 |
2020-01-16 |
Precigen, Inc. |
Ror-1 specific chimeric antigen receptors and uses thereof
|
|
JP2021530212A
(ja)
*
|
2018-07-13 |
2021-11-11 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California |
レトロトランスポゾンベースの送達媒体及びその使用方法
|
|
US12516099B2
(en)
|
2018-08-09 |
2026-01-06 |
Juno Therapeutics, Inc. |
Processes for generating engineered cells and compositions thereof
|
|
CN108949695A
(zh)
*
|
2018-08-14 |
2018-12-07 |
杭州荣泽生物科技有限公司 |
一种非病毒载体共表达il18的car-t细胞构建及其应用
|
|
US12497611B2
(en)
|
2018-08-17 |
2025-12-16 |
Yale University |
Compositions and methods for high-throughput activation screening to boost T cell effector function
|
|
CN110862967A
(zh)
*
|
2018-08-27 |
2020-03-06 |
天津天锐生物科技有限公司 |
一种不依赖细胞因子培养的自然杀伤细胞系silk-nk
|
|
EP3844186A4
(en)
|
2018-08-29 |
2022-08-17 |
National University of Singapore |
METHOD OF SPECIFIC STIMULATION OF SURVIVAL AND EXPANSION OF GENETICALLY MODIFIED IMMUNE CELLS
|
|
US12240915B2
(en)
|
2018-08-30 |
2025-03-04 |
Innovative Cellular Therapeutics Holdings, Ltd. |
Chimeric antigen receptor cells for treating solid tumor
|
|
CN112771166B
(zh)
|
2018-08-31 |
2025-03-04 |
诺伊尔免疫生物科技株式会社 |
表达car的t细胞和car表达载体
|
|
AU2019335014A1
(en)
*
|
2018-09-05 |
2021-03-25 |
Poseida Therapeutics, Inc. |
Allogeneic cell compositions and methods of use
|
|
CN109320615B
(zh)
*
|
2018-09-25 |
2023-09-22 |
上海恒润达生生物科技股份有限公司 |
靶向新型bcma的嵌合抗原受体及其用途
|
|
KR102816402B1
(ko)
|
2018-09-28 |
2025-06-04 |
옥테인 바이오테크 인코포레이티드 |
자기 분리
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
WO2020077180A1
(en)
*
|
2018-10-11 |
2020-04-16 |
Nantcell, Inc. |
Treatment of immunosuppressed subjects
|
|
US20210386788A1
(en)
|
2018-10-24 |
2021-12-16 |
Obsidian Therapeutics, Inc. |
Er tunable protein regulation
|
|
WO2020092696A1
(en)
*
|
2018-10-31 |
2020-05-07 |
Musc Foundation For Research Development |
Ex vivo activation and expansion of t cells for adoptive cell transfer therapy
|
|
CN111197032A
(zh)
*
|
2018-11-16 |
2020-05-26 |
上海斯丹赛生物技术有限公司 |
嵌合抗原受体细胞分泌治疗剂
|
|
US20220000921A1
(en)
*
|
2018-11-20 |
2022-01-06 |
Innovative Cellular Therapeutics Holdings, Ltd. |
Modified Cell Expressing Therapeutic Agent and Uses thereof
|
|
US10918667B2
(en)
|
2018-11-20 |
2021-02-16 |
Innovative Cellular Therapeutics CO., LTD. |
Modified cell expressing therapeutic agent and uses thereof
|
|
CA3120563A1
(en)
|
2018-11-26 |
2020-06-04 |
Nkarta, Inc. |
Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
|
|
KR20210111244A
(ko)
*
|
2018-11-30 |
2021-09-10 |
셀룰래리티 인코포레이티드 |
태반-유래 동종이계 car-t 세포 및 이의 용도
|
|
AU2019397033B2
(en)
|
2018-12-12 |
2023-06-29 |
Kite Pharma, Inc. |
Chimeric antigen receptors and CAR-T cells and methods of use
|
|
KR20210108406A
(ko)
|
2018-12-21 |
2021-09-02 |
론자 워커스빌 아이엔씨. |
바이러스 벡터의 자동화된 생산
|
|
EP3898932A4
(en)
|
2018-12-21 |
2022-08-03 |
Octane Biotech Inc. |
CAROUSEL FOR MODULAR BIOLOGICAL PRODUCTION UNITS
|
|
WO2020163695A1
(en)
*
|
2019-02-07 |
2020-08-13 |
Board Of Regents, The University Of Texas System |
Aspergillus antigen chimeric receptors and use thereof
|
|
CA3130671A1
(en)
|
2019-02-07 |
2020-08-13 |
Board Of Regents, The University Of Texas Systems |
Glucuronoxylomannan (gxm) receptor chimeric antigen receptors and use thereof
|
|
WO2020163454A1
(en)
|
2019-02-08 |
2020-08-13 |
Lonza Walkersville, Inc. |
Cell concentration methods and devices for use in automated bioreactors
|
|
EP3773918A4
(en)
|
2019-03-05 |
2022-01-05 |
Nkarta, Inc. |
CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY
|
|
WO2020198151A1
(en)
*
|
2019-03-22 |
2020-10-01 |
Spotlight Therapeutics |
Targeted active gene editing agent and methods of use
|
|
KR20210150446A
(ko)
*
|
2019-04-04 |
2021-12-10 |
상하이 파마슈티컬스 홀딩 컴퍼니 리미티드 |
종양 항원 인식 수용체를 함유하는 면역 세포 및 이의 적용
|
|
KR20210152536A
(ko)
|
2019-04-12 |
2021-12-15 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
조절 b 세포의 생산 방법 및 이의 용도
|
|
WO2021011907A1
(en)
|
2019-07-18 |
2021-01-21 |
Gpb Scientific, Inc. |
Ordered processing of blood products to produce therapeutically active cells
|
|
WO2021021804A1
(en)
*
|
2019-07-28 |
2021-02-04 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Methods, systems, and computer-readable media for predicting a cancer patient's response to immune-based or targeted therapy
|
|
WO2021019706A1
(ja)
*
|
2019-07-31 |
2021-02-04 |
国立大学法人信州大学 |
Ｃａｒ発現免疫細胞を含む細胞集団の製造方法
|
|
US12116578B2
(en)
|
2019-08-07 |
2024-10-15 |
APDN (B.V.1.) 1nc. |
Methods and systems of PCR-based recombinant adeno-associated virus manufacture
|
|
US20230092895A1
(en)
|
2019-08-30 |
2023-03-23 |
Obsidian Therapeutics, Inc. |
Tandem cd19 car-based compositions and methods for immunotherapy
|
|
WO2021046451A1
(en)
|
2019-09-06 |
2021-03-11 |
Obsidian Therapeutics, Inc. |
Compositions and methods for dhfr tunable protein regulation
|
|
WO2021050789A1
(en)
|
2019-09-10 |
2021-03-18 |
Obsidian Therapeutics, Inc. |
Ca2-il15 fusion proteins for tunable regulation
|
|
CN114502590A
(zh)
|
2019-09-18 |
2022-05-13 |
诺华股份有限公司 |
Entpd2抗体、组合疗法、以及使用这些抗体和组合疗法的方法
|
|
AU2020371562A1
(en)
*
|
2019-10-23 |
2022-06-09 |
The Council Of The Queensland Institute Of Medical Research |
Adoptive immunotherapy
|
|
EP4048773A4
(en)
|
2019-10-24 |
2024-01-03 |
Octane Biotech Inc. |
CELL CULTURE CHAMBER WITH IMPROVED CELL CONTACT SURFACES
|
|
US12163146B2
(en)
|
2019-11-11 |
2024-12-10 |
Lonza Walkersville, Inc. |
Quality control methods for automated cell processing
|
|
EP4065157A1
(en)
|
2019-11-26 |
2022-10-05 |
Novartis AG |
Cd19 and cd22 chimeric antigen receptors and uses thereof
|
|
WO2021113577A1
(en)
*
|
2019-12-05 |
2021-06-10 |
Immune Targeting Inc. |
Interleukin 15 fusion proteins and prodrugs, and compositions and methods thereof
|
|
WO2021127487A2
(en)
|
2019-12-20 |
2021-06-24 |
Regeneron Pharmaceuticals, Inc. |
Novel il2 agonists and methods of use thereof
|
|
JP2023508465A
(ja)
|
2019-12-28 |
2023-03-02 |
ジーピービー・サイエンティフィック・インコーポレイテッド |
粒子および細胞を処理するためのマイクロ流体カートリッジ
|
|
CN115210252A
(zh)
|
2020-02-04 |
2022-10-18 |
西雅图儿童医院（Dba西雅图儿童研究所） |
抗二硝基苯酚的嵌合抗原受体
|
|
US20230079539A1
(en)
|
2020-02-10 |
2023-03-16 |
Board Of Regents, The University Of Texas System |
Methods for rapid cloning and expression of hla class i cells
|
|
US12076343B2
(en)
|
2020-02-19 |
2024-09-03 |
Innovative Cellular Therapeutics Holdings, Ltd. |
Engineered safety in cell therapy
|
|
WO2021168376A1
(en)
*
|
2020-02-20 |
2021-08-26 |
Kite Pharma, Inc. |
Chimeric antigen receptor t cell therapy
|
|
IL296611A
(en)
*
|
2020-03-19 |
2022-11-01 |
Vascular Biosciences |
Car peptide for improved coronavirus survival
|
|
CN115916963A
(zh)
*
|
2020-03-27 |
2023-04-04 |
门德斯有限公司 |
白血病来源的经修饰细胞用于增强过继性细胞治疗的效力的离体用途
|
|
EP4127188A4
(en)
|
2020-03-31 |
2024-08-21 |
Walking Fish Therapeutics |
MODIFIED B CELLS AND METHODS OF USE THEREOF
|
|
KR20230006821A
(ko)
*
|
2020-03-31 |
2023-01-11 |
워킹 피쉬 테라퓨틱스 |
변형 b 세포 및 이의 사용 방법
|
|
US12043654B2
(en)
|
2020-06-02 |
2024-07-23 |
Innovative Cellular Therapeutics Holdings, Ltd. |
Anti-GCC antibody and CAR thereof for treating digestive system cancer
|
|
EP4171617A1
(en)
|
2020-06-30 |
2023-05-03 |
Mendus B.V. |
Use of leukemia-derived cells in ovarian cancer vaccines
|
|
CN113913459A
(zh)
*
|
2020-07-09 |
2022-01-11 |
杭州优凯瑞医药科技有限公司 |
一种应用非病毒方法制备高纯度嵌合抗原受体修饰的t细胞的方法及其应用
|
|
CN113913458A
(zh)
*
|
2020-07-09 |
2022-01-11 |
杭州优凯瑞医药科技有限公司 |
非病毒方法制备稳定高表达嵌合受体的nk细胞
|
|
WO2022011256A1
(en)
|
2020-07-10 |
2022-01-13 |
Precigen, Inc. |
Fusion constructs and methods of using thereof
|
|
JP7810446B2
(ja)
*
|
2020-09-17 |
2026-02-03 |
サニーベイ・バイオテック・インコーポレイテッド |
Ｈｅｒｖ－ｋ抗体治療薬
|
|
EP4243839A1
(en)
|
2020-11-13 |
2023-09-20 |
Catamaran Bio, Inc. |
Genetically modified natural killer cells and methods of use thereof
|
|
EP4251645A1
(en)
|
2020-11-25 |
2023-10-04 |
Catamaran Bio, Inc. |
Cellular therapeutics engineered with signal modulators and methods of use thereof
|
|
US11459372B2
(en)
|
2020-11-30 |
2022-10-04 |
Crispr Therapeutics Ag |
Gene-edited natural killer cells
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
KR20230118887A
(ko)
|
2020-12-03 |
2023-08-14 |
센츄리 쎄라퓨틱스 인코포레이티드 |
유전자 조작 세포 및 이의 용도
|
|
AR124414A1
(es)
|
2020-12-18 |
2023-03-22 |
Century Therapeutics Inc |
Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable
|
|
US20240117002A1
(en)
*
|
2020-12-23 |
2024-04-11 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
WO2022144632A1
(en)
|
2020-12-30 |
2022-07-07 |
Crispr Therapeutics Ag |
Compositions and methods for differentiating stem cells into nk cells
|
|
US12234473B2
(en)
|
2020-12-31 |
2025-02-25 |
Immatics US, Inc. |
CD8 polypeptides, compositions, and methods of using thereof
|
|
AU2022205683A1
(en)
*
|
2021-01-11 |
2023-07-06 |
Precigen, Inc. |
Chimeric receptor therapy
|
|
US20220133801A1
(en)
*
|
2021-01-19 |
2022-05-05 |
Obsidian Therapeutics, Inc. |
Administration of tumor infiltrating lymphocytes with membrane bound interleukin 15 to treat cancer
|
|
EP4305053A1
(en)
*
|
2021-03-11 |
2024-01-17 |
Kite Pharma, Inc. |
Improving immune cell function
|
|
KR20230167416A
(ko)
*
|
2021-04-08 |
2023-12-08 |
주식회사 지씨셀 |
키메라 항원 수용체 및 il-15를 포함하는 융합 단백질
|
|
WO2022242644A1
(zh)
*
|
2021-05-18 |
2022-11-24 |
赛斯尔擎生物技术（上海）有限公司 |
修饰细胞的方法
|
|
TW202307210A
(zh)
|
2021-06-01 |
2023-02-16 |
瑞士商諾華公司 |
Ｃｄ１９和ｃｄ２２嵌合抗原受體及其用途
|
|
EP4108247A1
(en)
|
2021-06-23 |
2022-12-28 |
Ostravska univerzita |
Urine progenitor cells for use in cancer therapy
|
|
JP2024527593A
(ja)
*
|
2021-07-09 |
2024-07-25 |
レジェンド バイオテック アイルランド リミテッド |
変異型ｉｌ－１５組成物及びその方法
|
|
EP4402155A4
(en)
*
|
2021-09-18 |
2025-12-24 |
Sunnybay Biotech Inc |
ANTI-HERV-K ANTIBODIES, CELL, VACCINE AND DRUG THERAPEUTIC AGENTS
|
|
JP2024537991A
(ja)
|
2021-10-14 |
2024-10-18 |
アーセナル バイオサイエンシズ インコーポレイテッド |
共発現されるｓｈＲＮＡと論理ゲートシステムとを有する免疫細胞
|
|
EP4180049A1
(en)
|
2021-11-16 |
2023-05-17 |
Ostravska univerzita |
Therapeutic composition for cancer treatment
|
|
US20250145950A1
(en)
*
|
2022-02-01 |
2025-05-08 |
Alaunos Therapeutics, Inc. |
Methods for Activation and Expansion of T Cells
|
|
CN118742810A
(zh)
*
|
2022-02-15 |
2024-10-01 |
凯德药业股份有限公司 |
从免疫疗法预测不良事件
|
|
US20250228940A1
(en)
*
|
2022-03-11 |
2025-07-17 |
Yale University |
Compositions and methods for efficient and stable genetic modification of eukaryotic cells
|
|
EP4504247A1
(en)
|
2022-04-04 |
2025-02-12 |
Gammadelta Therapeutics Ltd |
Novel gene armoring
|
|
CN119110845A
(zh)
*
|
2022-04-04 |
2024-12-10 |
伽马三角洲疗法有限公司 |
表达抗间皮素car的细胞
|
|
WO2023217796A1
(en)
|
2022-05-10 |
2023-11-16 |
Miltenyi Biotec B.V. & Co. KG |
Compositions comprising il-15, il-15 receptor alpha and the intracellular signaling domain of cd2 for immune cell therapy
|
|
KR20250013199A
(ko)
*
|
2022-05-27 |
2025-01-31 |
카이트 파마 인코포레이티드 |
세포 요법 작제물의 비-바이러스 전달
|
|
CN119698467A
(zh)
|
2022-06-08 |
2025-03-25 |
世纪治疗股份有限公司 |
衍生自遗传工程化以具有膜结合的il12的诱导多能干细胞的免疫效应细胞及其用途
|
|
CN115807020A
(zh)
*
|
2022-09-23 |
2023-03-17 |
卡瑞济(北京)生命科技有限公司 |
白介素15受体α装甲CAR-T细胞在降低白介素15诱导的细胞毒性中的用途
|
|
JP2026503179A
(ja)
*
|
2022-10-25 |
2026-01-28 |
キヴァーナ セラピューティクス インコーポレイテッド |
抗ｃｄ１９ ｃａｒ－ｔ細胞療法を使用したループス腎炎の治療方法
|
|
WO2024102838A1
(en)
|
2022-11-09 |
2024-05-16 |
Century Therapeutics, Inc. |
Engineered interleukin-7 receptors and uses thereof
|
|
AU2023375625A1
(en)
|
2022-11-10 |
2025-05-15 |
Century Therapeutics, Inc. |
Genetically engineered cells having anti-nectin4 chimeric antigen receptors, and uses thereof
|
|
EP4624498A1
(en)
*
|
2022-11-25 |
2025-10-01 |
Suzhou Grit Biotechnology Co., Ltd. |
Fusion polypeptide and use thereof
|
|
CN115873803B
(zh)
*
|
2022-11-28 |
2025-06-17 |
上海恩凯细胞技术有限公司 |
提高nk细胞存活和抗肿瘤活性的方法及应用
|
|
WO2024150828A1
(ja)
*
|
2023-01-12 |
2024-07-18 |
積水化学工業株式会社 |
遺伝子導入方法
|
|
WO2024153124A1
(zh)
*
|
2023-01-18 |
2024-07-25 |
南京传奇生物科技有限公司 |
经修饰的原代t细胞及其用途
|
|
CN116287201A
(zh)
*
|
2023-02-13 |
2023-06-23 |
河南大学 |
一种肺动脉高压标志物tcf-7基因或tcf-7蛋白及其应用
|
|
WO2025059162A1
(en)
|
2023-09-11 |
2025-03-20 |
Dana-Farber Cancer Institute, Inc. |
Car-engager containing il-2 variants to enhance the functionality of car t cells
|
|
WO2025101938A2
(en)
|
2023-11-10 |
2025-05-15 |
Century Therapeutics, Inc. |
Genetically engineered cells having multi-transmembrane domain chimeric antigen receptors utilizing g protein-coupled receptor scaffolds, and uses thereof
|
|
WO2025106626A1
(en)
|
2023-11-15 |
2025-05-22 |
Century Therapeutics, Inc. |
Genetically engineered cells expressing c-x-c chemokine receptor type 4, and uses thereof
|
|
WO2025226918A1
(en)
*
|
2024-04-24 |
2025-10-30 |
La Jolla Institute For Immunology |
Herv-k envelope protein binders and compositions and methods of use thereof
|
|
WO2026043482A1
(en)
*
|
2024-08-21 |
2026-02-26 |
Fenwal, Inc. |
Modified cells produced by a modular biological cell processing system
|
|
CN120365387B
(zh)
*
|
2025-06-25 |
2025-08-29 |
海南大学三亚南繁研究院 |
一种植物免疫诱抗蛋白EqBPIE1及其应用
|